Performance measures | Criteria for positive cancer diagnosis at CTC* | ||||||
Lesion size ≥10 mm | Lesion size ≥15 mm | Lesion size ≥20 mm | Lesion size ≥10 mm and uneven surface | Lesion size ≥10 mm and pericolic abnormality | Lesion size ≥10 mm and enlarged pericolic lymph nodes | Lesion size ≥15 mm and uneven surface, pericolic abnormality, or enlarged pericolic lymph nodes | |
Sensitivity, % (95% CI) | 87.5 (50.8 to 99.9) | 87.5 (50.8 to 99.9) | 62.5 (30.4 to 86.5) | 87.5 (50.8 to 99.9) | 62.5 (30.4 to 86.5) | 25 (6.3 to 59.9) | 87.5 (50.8 to 99.9) |
No. of lesions | 7/8 | 7/8 | 5/8 | 7/8 | 5/8 | 2/8 | 7/8 |
PPV, % (95% CI) | 17.5 (8.4 to 32.3) | 70 (39.2 to 89.7) | 100 (59.9 to 100) | 33.3 (17.1 to 54.8) | 100 (59.9 to 100) | 100 (36.9 to 100) | 77.8 (44.3 to 94.7) |
No. of lesions | 7/40† | 7/10 | 5/5 | 7/21 | 5/5 | 2/2 | 7/9 |